Literature DB >> 23031361

Hyperglycemia and arterial stiffness: the Atherosclerosis Risk in the Communities study.

Jonathan Rubin1, Vijay Nambi, Lloyd E Chambless, Michael W Steffes, Stephen P Juraschek, Josef Coresh, A Richey Sharrett, Elizabeth Selvin.   

Abstract

OBJECTIVES: Hyperglycemia has been associated with an increased risk of cardiovascular morbidity and mortality. Although numerous studies have demonstrated that hyperglycemia is associated with the atherosis component of atherosclerosis, limited studies have addressed the independent role of hyperglycemia in the pathophysiology of sclerotic vascular disease. We hypothesized that hyperglycemia, as assessed by hemoglobin A1c (HbA1c), would be independently associated two common indices of arterial stiffness (pressure-strain elastic modulus (Ep) and Young's elastic modulus (YEM)).
METHODS: We examined the cross-sectional association between HbA1c and arterial stiffness using B-mode ultrasound examination of the carotid artery in 9050 participants from the community-based Atherosclerosis Risk in Communities (ARIC) study. We used multivariable linear and logistic regression models to characterize the association between HbA1c and increased Ep and YEM.
RESULTS: Higher values of HbA1c were associated in a graded fashion with increased arterial stiffness (P-trend < 0.001 for both EP and YEM). After adjusting for traditional risk factors, increasing HbA1c deciles were significantly associated with elevated EP (OR for the highest decile of HbA1c compared to the lowest, 2.01, 95% CI: 1.30, 3.11) and YEM (OR = 1.71, 95% CI: 1.15, 2.55).
CONCLUSION: Elevated HbA1c is associated with measures of increased arterial stiffness, even after accounting for arterial wall thickness. This is consistent with the hypothesis that hyperglycemia contributes to arterial stiffness beyond its effects on atherosis and suggests that hyperglycemia is associated with altered material within the arterial wall.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23031361      PMCID: PMC3936879          DOI: 10.1016/j.atherosclerosis.2012.09.003

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  33 in total

1.  A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.

Authors:  P V Vaitkevicius; M Lane; H Spurgeon; D K Ingram; G S Roth; J J Egan; S Vasan; D R Wagle; P Ulrich; M Brines; J P Wuerth; A Cerami; E G Lakatta
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Eric Y Yang; Lloyd Chambless; A Richey Sharrett; Salim S Virani; Xiaoxi Liu; Zhengzheng Tang; Eric Boerwinkle; Christie M Ballantyne; Vijay Nambi
Journal:  Stroke       Date:  2011-10-27       Impact factor: 7.914

3.  Nonenzymatic browning in vivo: possible process for aging of long-lived proteins.

Authors:  V M Monnier; A Cerami
Journal:  Science       Date:  1981-01-30       Impact factor: 47.728

4.  An approach to the noninvasive periodic assessment of arterial elasticity in the young.

Authors:  W A Riley; R W Barnes; H M Schey
Journal:  Prev Med       Date:  1984-03       Impact factor: 4.018

5.  Glucose level is a major determinant of carotid intima-media thickness in patients with hypertension and hyperglycemia.

Authors:  Anne-Isabelle Tropeano; Pierre Boutouyrie; Sandrine Katsahian; Brigitte Laloux; Stéphane Laurent
Journal:  J Hypertens       Date:  2004-11       Impact factor: 4.844

Review 6.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

7.  Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study.

Authors:  Ronald M A Henry; Piet J Kostense; Annemieke M W Spijkerman; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Otto Kamp; Nico Westerhof; Lex M Bouter; Coen D A Stehouwer
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

8.  Effect of insulin on growth of cultured human arterial smooth muscle cells.

Authors:  B Pfeifle; H Ditschuneit
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

9.  Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow: comparative study of indirect systolic, diastolic, and mean brachial artery pressure with simultaneous direct ascending aortic pressure measurements.

Authors:  K M Borow; J W Newburger
Journal:  Am Heart J       Date:  1982-05       Impact factor: 4.749

10.  Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study.

Authors:  Miranda T Schram; Ronald M A Henry; Rob A J M van Dijk; Piet J Kostense; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Lex M Bouter; Nico Westerhof; Coen D A Stehouwer
Journal:  Hypertension       Date:  2003-12-29       Impact factor: 10.190

View more
  15 in total

Review 1.  Therapeutic approaches to drug targets in atherosclerosis.

Authors:  Prasad G Jamkhande; Prakash G Chandak; Shashikant C Dhawale; Sonal R Barde; Priti S Tidke; Ram S Sakhare
Journal:  Saudi Pharm J       Date:  2013-11-05       Impact factor: 4.330

2.  Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage.

Authors:  Elizabeth Selvin; Mariana Lazo; Yuan Chen; Lu Shen; Jonathan Rubin; John W McEvoy; Ron C Hoogeveen; A Richey Sharrett; Christie M Ballantyne; Josef Coresh
Journal:  Circulation       Date:  2014-08-22       Impact factor: 29.690

Review 3.  Pathophysiology of cardiovascular disease in diabetes mellitus.

Authors:  Gerardo Rodriguez-Araujo; Hironori Nakagami
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-02-14

4.  Fibronectin-Integrin α5 Signaling in Vascular Complications of Type 1 Diabetes.

Authors:  Minghao Chen; Rui Hu; Cristina Cavinato; Zhenwu W Zhuang; Jiasheng Zhang; Sanguk Yun; Pablo Fernandez Tussy; Abhishek Singh; Sae-Il Murtada; Keiichiro Tanaka; Min Liu; Carlos Fernández-Hernando; Jay D Humphrey; Martin A Schwartz
Journal:  Diabetes       Date:  2022-09-01       Impact factor: 9.337

Review 5.  Diabetes Mellitus, Arterial Wall, and Cardiovascular Risk Assessment.

Authors:  Michaela Kozakova; Carlo Palombo
Journal:  Int J Environ Res Public Health       Date:  2016-02-06       Impact factor: 3.390

Review 6.  Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes.

Authors:  Claudia R L Cardoso; Gil F Salles
Journal:  Int J Mol Sci       Date:  2016-12-06       Impact factor: 5.923

7.  Clinical relevance of gemstone spectral CT in the diagnosis of carotid atherosclerosis.

Authors:  Jing-Jian Wang; Shu-Jie Fan; Long-Long Wang; Yan-Zhong Gao; Xiao-Juan Liu
Journal:  Exp Ther Med       Date:  2017-04-13       Impact factor: 2.447

8.  Nondiabetic Glucometabolic Status and Progression of Aortic Stiffness: The Whitehall II Study.

Authors:  Carmel M McEniery; Ian B Wilkinson; Nanna B Johansen; Daniel R Witte; Archana Singh-Manoux; Mika Kivimaki; Adam G Tabak; Eric J Brunner; Martin J Shipley
Journal:  Diabetes Care       Date:  2017-01-25       Impact factor: 19.112

Review 9.  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.

Authors:  Dimitrios Patoulias; Christodoulos Papadopoulos; Konstantinos Stavropoulos; Ioanna Zografou; Michael Doumas; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-14       Impact factor: 3.738

10.  Polyethylene glycol-modified dendrimer-entrapped gold nanoparticles enhance CT imaging of blood pool in atherosclerotic mice.

Authors:  Kaichuang Ye; Jinbao Qin; Zhiyou Peng; Xinrui Yang; Lijia Huang; Fukang Yuan; Chen Peng; Mier Jiang; Xinwu Lu
Journal:  Nanoscale Res Lett       Date:  2014-09-26       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.